FXS patients showed reduced expression of WNT7a and reduced β-catenin-dependent signaling, and in the brain of Fmr1 (FMRP gene) knockout mice the translation of Wnt2 mRNA was found to be reduced [93,94,95,96]. The gene discussed is FMR1; the disease is fragile X syndrome.